Ebola survivor Amber Vinson will donate blood to a drug development company that hopes to develop a beneficial drug that could help other victims.
Vinson’s blood, which was exposed to the deadly virus and was subsequently cleared of it, is a strong candidate for such a venture because of its antibodies, officials at Austin, Texas-based XBiotech said.
“We assume that the people who survive Ebola have survived it largely because they have some very good antibodies,” John Simard, XBiotech’s CEO said.
Vinson, 29, contracted the virus while a nurse at Texas Health Presbyterian Hospital in Dallas caring for Thomas Duncan, a Liberian national who died of the disease Oct. 8. Fellow nurse Nina Pham, 26, also contracted the virus and survived.
“I’m one of the few people here in the states that can provide the blood for research,” Vinson said. “Maybe something wonderful can come out of it, so I want to do my part to help.”
SOURCE: USA Today
Byron Harris, WFAA-TV, Dallas